What Drove Coherus (CHRS) Stock’s Extended Session Surge?
Coherus BioSciences, Inc. (NASDAQ: CHRS) shares experienced a notable upswing of 37.16%, reaching $2.99 in the extended trading session on Tuesday. In the regular trading session, Coherus stock also displayed a commendable increase of 7.92%, concluding at $2.18. This surge in CHRS stock value ensued subsequent to the announcement of regulatory approval. Coherus (CHRS) yesterday …
What Drove Coherus (CHRS) Stock’s Extended Session Surge? Read More »